Meeting acute migraine treatment needs through novel treatment formulations

The Acute Treatment of Episodic and Chronic Migraine in the USA

(2009) ME Bigal et al.   CEPHALALGIA

Purinergic Receptors and Pain

(2009) Geoffrey Burnstock   CURRENT PHARMACEUTICAL DESIGN

Needle-Free Subcutaneous Sumatriptan (Sumavel™ DosePro™): Bioequivalence and Ease of Use

(2009) Jan Lewis Brandes et al.   HEADACHE

Reduced Adverse Event Profile of Orally Inhaled DHE (MAP0004) vs IV DHE: Potential Mechanism

(2009) Robert O. Cook et al.   HEADACHE

A Randomized, Double Blind, Placebo-Controlled Study of MAP0004 in Adult Patients With Migraine

(2009) Sheena K. Aurora et al.   HEADACHE

Elevated Saliva Calcitonin Gene-Related Peptide Levels During Acute Migraine Predict Therapeutic Response to Rizatriptan

(2009) Roger K. Cady et al.   HEADACHE

Inhibition of P2X receptor-mediated inward current by protein kinase C in small-diameter dorsal root ganglion neurons of adult rats

(2009) Bi-Hua Bie et al.   Neuroscience Bulletin

Defining a Pathway to Discovery from Bench to Bedside: The Trigeminovascular System and Sensitization

(2008) Michael A. Moskowitz   HEADACHE

Tonabersat Inhibits Trigeminal Ganglion Neuronal-Satellite Glial Cell Signaling

(2008) Srikanth Damodaram et al.   HEADACHE

Could glial activation be a factor in migraine?

(2008) Jim Bartley   MEDICAL HYPOTHESES

5-hydroxytryptamine1B receptor and triptan response in migraine, lack of association with common polymorphisms

(2007) Daniela Velati et al.   EUROPEAN JOURNAL OF PHARMACOLOGY